OMER peer analysis
Omeros (OMER) against its competitors: price, today's move, 1-year return and market value side by side.
OMER and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ANAB AnaptysBio | $46.91 | -2.84% | 28.24% | $1.44B |
| BHVN Biohaven | $15.45 | 1.91% | -10.17% | $2.33B |
| CGEM Cullinan Therapeutics | $14.93 | -0.67% | 72.40% | – |
| CGEN Compugen | $1.98 | 0.00% | 11.86% | $187.56M |
| CRVS Corvus Pharmaceuticals | $9.70 | -3.29% | 20.65% | $843.73M |
| MGNX MacroGenics | $2.33 | -2.92% | 40.36% | $152.88M |
| MREO Mereo BioPharma | $0.29 | 0.17% | -84.74% | $46.23M |
| NKTR Nektar | $36.95 | -4.94% | -43.09% | $1.33B |
| RCUS Arcus Biosciences | $17.85 | -1.87% | -9.48% | $2.32B |
| XNCR Xencor | $29.66 | -0.54% | 101.63% | $2.22B |
| OMER Omeros | $17.83 | -3.31% | 143.25% | $1.33B |
- OMER's peers: ANAB (AnaptysBio), BHVN (Biohaven), CGEM (Cullinan Therapeutics), CGEN (Compugen), CRVS (Corvus Pharmaceuticals), MGNX (MacroGenics), MREO (Mereo BioPharma), NKTR (Nektar).
Updated 2026-11-03 11:33 UTC